Wendy Schreurs

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

Bo Jan Noordman, Manon C.W. Spaander, Roelf Valkema et al. · The Lancet Oncology · 2018 · 320 citations

Residual Disease, Surgical Oncology, Esophageal Cancer +11

Influence of gray level discretization on radiomic feature stability for different CT scanners, tube currents and slice thicknesses: a comprehensive phantom study

Ruben T. H. M. Larue, Janita E. van Timmeren, Evelyn E.C. de Jong et al. · Acta Oncologica · 2017 · 279 citations · Full text

Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer

Ruben T. H. M. Larue, Remy Klaassen, Arthur Jochems et al. · Acta Oncologica · 2018 · 89 citations · Full text

4DCT imaging to assess radiomics feature stability: An investigation for thoracic cancers

Ruben T. H. M. Larue, Lien Van De Voorde, Janita E. van Timmeren et al. · Radiotherapy and Oncology · 2017 · 72 citations · Full text

The value of post-neoadjuvant therapy PET-CT in the detection of interval metastases in esophageal carcinoma

R.L.G.M. Blom, Wendy Schreurs, H. J. Belgers et al. · European Journal of Surgical Oncology · 2011 · 42 citations · Full text

Positron Emission Tomography, Esophageal Cancer, Oncologic Imaging +10